Post-operative outcomes in anonymous living liver donors: What motivates individuals to donate to strangers.
LDLT
anonymous liver donors
directed living liver donors
living liver donor
non-directed living liver donors
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
17
07
2021
received:
27
01
2021
accepted:
19
07
2021
pubmed:
23
7
2021
medline:
3
2
2022
entrez:
22
7
2021
Statut:
ppublish
Résumé
Anonymous living donor liver transplantation (LDLT) is a strategy to address the shortage of available transplantable livers; however, few studies have been conducted on this population. The objective of this study was to describe the motivations and medical, psychosocial, and financial outcomes of anonymous living liver donors. Between 2010-2019, 116 anonymous living liver donors were evaluated, 59 (51.7%) of whom proceeded to surgery. A subset of 21 anonymous donors were matched to biologically/emotionally related donors according to age, gender, race, and duration since surgery. A medical chart review and post-surgical interviews were performed to assess medical and financial outcomes. The primary motivation for donors was an unselfish desire to help others (43, 72.9%). A total of 13 (22%) anonymous donors experienced complications. Of these, 7 (11.9%) were grade I Clavien-Dindo classification, 5 (8.5%) grade II, 1 was grade III (1.7%); and no patients had grade IV-V Clavien-Dindo complications. Increased anxiety was reported by 3 (5.1%) donors, and one donor reported clinical levels of depression (1.7%). Within the matched controls, anonymous donors were not significantly different to biologically/emotionally related donors with regard to surgical complications, psychosocial, or financial outcomes. Allowing a greater number of anonymous donors may facilitate the reduction of the waitlist for liver transplant candidates.
Sections du résumé
BACKGROUND
Anonymous living donor liver transplantation (LDLT) is a strategy to address the shortage of available transplantable livers; however, few studies have been conducted on this population. The objective of this study was to describe the motivations and medical, psychosocial, and financial outcomes of anonymous living liver donors.
METHODS
Between 2010-2019, 116 anonymous living liver donors were evaluated, 59 (51.7%) of whom proceeded to surgery. A subset of 21 anonymous donors were matched to biologically/emotionally related donors according to age, gender, race, and duration since surgery. A medical chart review and post-surgical interviews were performed to assess medical and financial outcomes.
RESULTS
The primary motivation for donors was an unselfish desire to help others (43, 72.9%). A total of 13 (22%) anonymous donors experienced complications. Of these, 7 (11.9%) were grade I Clavien-Dindo classification, 5 (8.5%) grade II, 1 was grade III (1.7%); and no patients had grade IV-V Clavien-Dindo complications. Increased anxiety was reported by 3 (5.1%) donors, and one donor reported clinical levels of depression (1.7%). Within the matched controls, anonymous donors were not significantly different to biologically/emotionally related donors with regard to surgical complications, psychosocial, or financial outcomes.
CONCLUSIONS
Allowing a greater number of anonymous donors may facilitate the reduction of the waitlist for liver transplant candidates.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14438Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Removal Reasons by Year. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# Published 2019. Accessed: May 3, 2019
Living Donation Facts and Resources. UNOS. https://unos.org/transplant/living-donation/ Published 2019. Accessed: June 15, 2019.
Saidi RF, Henjazii Kenari SK. Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med. 2014;5(3):87-96.
Brown RS. Live donors in liver transplantation. Gastroenterology. 2008;134(6):1802. 13.
Donors Recovered in the U.S. by Donor Type: Liver. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# Published 2021. Accessed: May 15, 2021.
Reichman TW, Katchman H, Tanaka T, et al. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes. Transpl Int. 2013;26(8):780-787.
Ohdan H. Is living donor liver transplantation really equivalent to deceased donor liver transplantation?. Transpl Int. 2013;26(8):778-779.
Shah SA, Levy GA, Greig PD, et al. Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant. 2007;7(4):998-1002.
Berg CL, Merion RM, Shearon TH, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011;54(4):1313-1321.
Shen C-J, Huang H-L, Chen K-H, et al. Comparison of liver function, emotional status, and quality of life of living liver donors in Taiwan. Transplant Proc. 2016;48(4):1007-1011.
Renz JF, Roberts JP. Long-term complications of living donor liver transplantation. Liver Transpl. 2000;6(6B):s73-s76.
Reichman TW, Fox A, Adcock L, et al. Anonymous living liver donation: donor profiles and outcomes. Am J Transplant. 2010;10(9):2099-2104.
Raza MH, Aziz H, Kaur N, et al. Global experience and perspective on anonymous nondirected live donation in living donor liver transplantation. Clin Transplant. 2020;34(4):e13836.
Maple H, Chilcot J, Burnapp L, et al. Motivations, outcomes, and characteristics of unspecified (nondirected altruistic) kidney donors in the United Kingdom. Transplantation. 2014;98(11):1182-1189.
Rodrigue JR, Schutzer ME, Paek M, Morrissey P. Altruistic kidney donation to a stranger: psychosocial and functional outcomes at two US transplant centers. Transplantation. 2011;91(7):772-778.
Dew MA, Butt Z, Humar A, Dimartini AF. Long-term medical and psychosocial outcomes in living liver donors. Am J Transplant. 2016;17(4):880-892.
Raza MH, Jackson WE, Dell A, et al. Health-related quality of life after anonymous nondirected living liver donation: a multicenter collaboration. Am J Transplant. 2021;21:1056-1067.
Walter M, Bronner E, Pascher A, et al. Psychosocial outcome of living donors after living donor liver transplantation: a pilot study. Clin Transplant. 2002;16(5):339-344.
Massey EK, Kranenburg LW, Zuidema WC, et al. Encouraging psychological outcomes after altruistic donation to a stranger. Am J Transplant. 2010;10(6):1445-1452.
Wright L, Ross K, Abbey S, et al. Living anonymous liver donation: case report and ethical justification. Am J Transplant. 2007;7(4):1032-1035.
Popp FC. Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population. J Med Ethics. 2006;32(7):389-894.
Jendrisak M, Hong B, Shenoy S, et al. Altruistic living donors: evaluation for nondirected kidney or liver donation. Am J Transplant. 2005;6(1):115-120.
DuBay DA, Holtzman S, Adcock L, et al. Adult right-lobe living liver donors: quality of life, attitudes and predictors of donor outcomes. Am J Transplant. 2009;9(5):1169-1178.
Goldaracena N, Jung J, Aravinthan AD, et al. Donor outcomes in anonymous live liver donation. J Hepatol. 2019;71(5):951-959.
Wiseman JF, Jacobs CL, Larson DB, et al. Financial burden borne by laparoscopic living kidney donors. Transplantation. 2017;101(9):2253-2257.
Tong A, Craig JC, Wong G, et al. It was just an unconditional gift.” Self-reflections of non-directed living kidney donors. J Clin Transl Res. 2012;26(4):589-599.
Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111:518-526.
Kroenke K, Spitzer RL, Williams JB. The Patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292.
Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348-353.
Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
Huo T, Guo Y, Shenkman E, Muller K. Assessing the reliability of the short form 12 (SF-12) health survey in adults with mental health conditions: a report from the wellness incentive and navigation (WIN) study. Health Qual Life Outcomes. 2018;16(1):34.
Abecassis MM, Fisher RA, Olthoff KM, et al. A2ALL Study Group. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant. 2012;12(5):1208-1217.
Butt Z, Dew MA, Liu Q, et al. Psychological outcomes of living liver donors from a multicenter perspective study: results from the adult-to-adult living donor liver transplantation cohort study2 (A2ALL-2). Am J Transplant. 2017;17(5):1267-1277.
Ommen ES, Rudow DL, Medapalli RK, et al. When good intentions are not enough: obtaining follow-up data in living kidney donors. Am J Transplant. 2011;11(12):2575-2581.
Corbett C, Armstrong MJ, Neuberger J. Tobacco smoking and solid organ transplantation. Transplant J. 2012;94(10):979-987.
DiMartini A, Dew MA, Liu Q, et al. Social and financial outcomes of living liver donation: a prospective investigation within the adult-to-adult living donor liver transplantation cohort study 2 (A2ALL-2). Am J Transplant. 2017;17(4):1081-1096. J.
Jacobs CL, Roman D, Garvey C, et al. Twenty-two nondirected kidney donors: an update on a single centers experience. Am J Transplant. 2004;4(7):1110-1116.